Free Trial
OTC:AKBLF

ALK-Abelló A/S (AKBLF) Stock Price, News & Analysis

ALK-Abelló A/S logo
$22.05 0.00 (0.00%)
(As of 11/22/2024 ET)

About ALK-Abelló A/S Stock (OTC:AKBLF)

Key Stats

Today's Range
$22.05
$22.05
50-Day Range
$22.05
$27.03
52-Week Range
$13.25
$27.03
Volume
N/A
Average Volume
596 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food. It also provides consumer healthcare solution, which include Digital eco-system, a platform which connect and engages with allergy sufferers in the disease journey through tools and e-commerce offerings that supports, guidance and relief, and smoothing the path to allergy immunotherapy treatment. In addition, the company offers diagnostic allergy solutions through testing by skin prick test or blood test; and emergency treatment, such as intra-muscular injection of adrenaline for the treatment of acute life-threatening allergic reactions, including Anaphylaxis. The company has a collaboration with Torii Pharmaceutical Co., Ltd. to develop, market and distribute allergy immunotherapy tablet for the treatment of grass pollen allergy. ALK-Abelló A/S was founded in 1923 and is headquartered in Horsholm, Denmark.

Receive AKBLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ALK-Abelló A/S and its competitors with MarketBeat's FREE daily newsletter.

AKBLF Stock News Headlines

DPBSF Dampskibsselskabet Norden A/S
A “Thank You Gift” From Pres. Trump - Genius
The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…
AKBLF ALK-Abelló A/S
ALK upgrades its full-year revenue and earnings outlook
Alaska Air (ALK) Receives a Buy from Seaport Global
See More Headlines

AKBLF Stock Analysis - Frequently Asked Questions

ALK-Abelló A/S's stock was trading at $13.25 on January 1st, 2024. Since then, AKBLF shares have increased by 66.4% and is now trading at $22.05.
View the best growth stocks for 2024 here
.

Shares of AKBLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
2,824
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (OTC:AKBLF) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners